Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Oct 4;57(10):1061.
doi: 10.3390/medicina57101061.

Bullous Pemphigoid and Other Pemphigoid Dermatoses

Affiliations
Review

Bullous Pemphigoid and Other Pemphigoid Dermatoses

Valeryia Pratasava et al. Medicina (Kaunas). .

Abstract

The pemphigoid family of dermatoses is characterized by autoimmune subepidermal blistering. The classic paradigm for pemphigoid, and the most common member, is bullous pemphigoid. Its variable clinical presentation, with or without frank bullae, is linked by significant pruritus afflicting the elderly. Mucous membrane pemphigoid is an umbrella term for a group of subepidermal blistering dermatoses that favor the mucosal membranes and can scar. Epidermolysis bullosa acquisita is a chronic blistering disorder characterized by skin fragility, sensitivity to trauma, and its treatment-refractory nature. Clinicians that encounter these pemphigoid disorders may benefit from an overview of their clinical presentation, diagnostic work-up, and therapeutic management, with an emphasis on the most frequently encountered pemphigoid disease, bullous pemphigoid.

Keywords: blistering; bullous; cicatricial; diagnosis; epidermolysis bullosa acquisita; mucous membrane; pemphigoid; vesiculobullous.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Bullous pemphigoid. Tense bullae overlying erythematous to urticarial plaques on acral skin.
Figure 2
Figure 2
Diagnostic work-up of pemphigoid dermatoses. BP = bullous pemphigoid, MMP = mucous membrane pemphigoid, EBA = epidermolysis bullosa acquisita.
Figure 3
Figure 3
Urticarial bullous pemphigoid. Eosinophilic spongiosis characterized by pseudovacuolar change, eosinophil exocytosis, and dermal eosinophilia.
Figure 4
Figure 4
Bullous pemphigoid treatment algorithm.
Figure 5
Figure 5
Epidermolysis bullosa acquisita treatment algorithm.
Figure 6
Figure 6
Mucous membrane pemphigoid treatment algorithm.

References

    1. Langan S.M., Smeeth L., Hubbard R., Fleming K.M., Smith C.J.P., West J. Bullous pemphigoid and pemphigus vulgaris--incidence and mortality in the UK: Population based cohort study. BMJ. 2008;337:a180. doi: 10.1136/bmj.a180. - DOI - PMC - PubMed
    1. Kridin K., Ludwig R. The Growing Incidence of Bullous Pemphigoid: Overview and Potential Explanations. Front. Med. 2018;5:220. doi: 10.3389/fmed.2018.00220. - DOI - PMC - PubMed
    1. Miyamoto D., Santi C.G., Aoki V., Maruta C.W. Bullous pemphigoid. An. Bras. Dermatol. 2019;94:133–146. doi: 10.1590/abd1806-4841.20199007. - DOI - PMC - PubMed
    1. Amber K.T., Murrell D.F., Schmidt E., Joly P., Borradori L. Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management. Clin. Rev. Allergy Immunol. 2017;54:26–51. doi: 10.1007/s12016-017-8633-4. - DOI - PubMed
    1. Xu H.-H., Werth V.P., Parisi E., Sollecito T.P. Mucous Membrane Pemphigoid. Dent. Clin. N. Am. 2013;57:611–630. doi: 10.1016/j.cden.2013.07.003. - DOI - PMC - PubMed